Exact says it plans to launch three new cancer tests in 2025: Cologuard Plus, next-generation colorectal cancer screening test, Oncodetect, molecular residual disease test, and Cancerguard, multi-cancer screening test.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Notable companies reporting after market close
- Options Volatility and Implied Earnings Moves Today, February 19, 2025
- Options Volatility and Implied Earnings Moves This Week, February 17 – February 20, 2025
- EXAS Upcoming Earnings Report: What to Expect?
- Exact Sciences downgraded to Mixed from Positive view at OTR Global